Search

… Tea will be served at 12:45 p.m. , immediately preceding the seminar. Audience This seminar is open to the research community. Location Memorial Sloan Kettering Cancer Center Zuckerman Research Center 417 East 68th Street Room ZRC-Auditorium  New York, NY 10065 Speaker(s) Alberto Ciccia, PhD Associate

… Full Title A Global Pivotal Study in Participants with KRAS G12C-Mutant, Locally Advanced or Metastatic Non-Small Cell Lung Cancer Comparing First-Line Treatment of LY3537982 and Pembrolizumab vs Placebo and Pembrolizumab in those with PD-L1 expression >=50% or LY3537982 and Pembrolizumab, Pemetrexed

… Job Title Research Fellow Degree PhD Email [email protected] Lab Fax 646-422-2355 Lab Phone 212-639-5953

Learn about Memorial Sloan Kettering’s approach to diagnosing bladder cancer.

… Before you start treatment, your doctor first will get a clear understanding of the cause of your symptoms. To make their diagnosis, MSK experts learn about your medical history and overall health. They will give you a thorough exam and diagnostic tests, such as: Cystoscopy and Transurethral Resection

… SK2010-068 Description Caki-2 is a human clear cell renal cell carcinoma (ccRCC) line that displays epithelial morphology and grows in adherent culture. These cells are a useful preclinical model to study renal cancer. They are relatively less sensitive to 5-fluorouracil and sorafenib (multi-kinase inhibitor

… Job Title Former Undergraduate Researcher Current Position Medical Student, Jacobs School of Medicine and Biomedical Sciences Honors & Awards ABRCMS Lightning Talk Award in Cancer Biology (2021) Macaulay Honors Scholarship (Full 4-year Merit Tuition Scholarship) (2018-2021) Dean’s List (2018-2021) Senator

Memorial Sloan Kettering nurse practitioner Jennifer Cagney specializes in caring for people who have had breast cancer.

… Job Title Nurse Practitioner I am a nurse practitioner with special training in breast cancer survivorship issues. I am a graduate of University of Pennsylvania’s nurse practitioner program and joined Memorial Sloan Kettering in 2012. I focus on the long-term effects of cancer treatment and am dedicated

Naltrexone is an older drug that is used clinically to treat opioid and alcohol addictions. More recently, low-dose naltrexone has been promoted as a safe and inexpensive way to treat various conditions.

… Common Name LDN What is it? Naltrexone is an older drug that was developed in the 1960s and approved for medical use by the FDA in the 1980s. It is used clinically to treat opioid and alcohol addictions. More recently, low-dose naltrexone (LDN) has been promoted as a safe and inexpensive way to treat

Researchers have shown how CH, a blood condition related to aging, affects cancer outcomes — through a phenomenon called tumor-infiltrating clonal hematopoiesis.

… Thursday, April 24, 2025 Doctors and scientists have known for nearly a decade that a precancerous blood condition called  clonal hematopoiesis (CH) is present in one in three patients with solid tumors and is associated with poor cancer outcomes. People with CH are less likely to respond to treatment

I am a plastic and reconstructive surgeon with special training in complex reconstruction following treatment for breast cancer, head and neck cancer, cancers of the chest and extremities, as well as skin cancers. I see patients at the David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center and perform procedures at Memorial Hospital and the Josie Robertson Surgery Center in New York City.

… Plastic & Reconstructive Surgeon Job Title Assistant Attending Surgeon I am a plastic and reconstructive surgeon with special training in complex reconstruction following treatment for breast cancer , head and neck cancer , cancers of the chest and extremities, as well as skin cancers . I see patients